metastatic gastric cancer: indications and impact of angiogenesis inhibitors
Published 7 years ago • 776 plays • Length 10:54Download video MP4
Download video MP3
Similar videos
-
8:17
metastatic gastric cancer: indications and impact of targeting the her2 pathway?
-
8:01
metastatic gastric cancer: indications and impact of stem-cell inhibition
-
18:58
mechanisms of angiogenesis inhibitors in metastatic colorectal cancer
-
20:04
metastatic gastric cancer: new targeted agents in metastatic gastric cancer
-
14:29
targeting her 2 and angiogenesis in gastric cancer: what is the impact
-
15:48
targeting her 2 and angiogenesis in gastric cancer: what is the impact?
-
10:49
part 3: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
41:03
part 1: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
26:41
metastatic gastric cancer: where are we with check-point inhibitors in gastric cancer?
-
15:55
enhancing outcomes in metastatic colorectal cancer with angiogenesis inhibitors
-
2:34
dr. kunz on angiogenesis inhibitors for the treatment of metastatic gastric cancer
-
32:17
part 2: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
20:21
check-point inhibitors in esophageal and gastric cancer: when and for whom?
-
23:04
carcinogenesis of gastric cancer through the eyes of a pathologist
-
22:39
gastric cancer: update on first-line therapies
-
23:48
improving the outcome of patients with metastatic pancreatic cancer
-
8:50
adjuvant treatment in gastric cancer: the surgical point of view
-
19:01
new agents in gastric cancer
-
2:01
dr. fuchs on targeting angiogenesis in gastric cancer